Call Options

14 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$18.05 - $24.02 $90,250 - $120,100
-5,000 Reduced 9.29%
48,800 $905,000
Q2 2024

Aug 13, 2024

SELL
$18.65 - $28.5 $721,755 - $1.1 Million
-38,700 Reduced 41.84%
53,800 $1.04 Million
Q1 2024

May 14, 2024

BUY
$24.74 - $35.13 $2.13 Million - $3.03 Million
86,200 Added 1368.25%
92,500 $2.5 Million
Q4 2023

Feb 13, 2024

SELL
$21.62 - $37.21 $462,668 - $796,294
-21,400 Reduced 77.26%
6,300 $225,000
Q3 2023

Nov 13, 2023

SELL
$27.34 - $55.37 $1.81 Million - $3.66 Million
-66,100 Reduced 70.47%
27,700 $783,000
Q2 2023

Aug 11, 2023

BUY
$26.1 - $49.92 $1.79 Million - $3.42 Million
68,600 Added 272.22%
93,800 $4.68 Million
Q1 2023

May 12, 2023

BUY
$18.09 - $27.61 $274,968 - $419,672
15,200 Added 152.0%
25,200 $663,000
Q3 2022

Nov 14, 2022

SELL
$23.95 - $34.71 $71,850 - $104,130
-3,000 Reduced 23.08%
10,000 $250,000
Q2 2022

Aug 12, 2022

SELL
$21.39 - $35.9 $1.62 Million - $2.71 Million
-75,600 Reduced 85.33%
13,000 $343,000
Q1 2022

May 13, 2022

BUY
$24.84 - $36.12 $755,136 - $1.1 Million
30,400 Added 52.23%
88,600 $3.02 Million
Q4 2021

Feb 11, 2022

BUY
$33.38 - $59.25 $96,802 - $171,825
2,900 Added 5.24%
58,200 $2.03 Million
Q3 2021

Nov 12, 2021

BUY
$53.75 - $76.55 $1.8 Million - $2.56 Million
33,400 Added 152.51%
55,300 $3.02 Million
Q2 2021

Aug 13, 2021

BUY
$59.02 - $78.8 $560,690 - $748,600
9,500 Added 76.61%
21,900 $1.66 Million
Q1 2021

May 14, 2021

BUY
$64.61 - $113.09 $801,164 - $1.4 Million
12,400 New
12,400 $946,000

Others Institutions Holding SDGR

About Schrodinger, Inc.


  • Ticker SDGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 62,028,400
  • Market Cap $1.22B
  • Description
  • Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences i...
More about SDGR
Track This Portfolio

Track Peak6 Investments LLC Portfolio

Follow Peak6 Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.